WHO and Switzerland launch BioHub for pathogen storage and analysis
The WHO and Swiss Confederation are set to launch a BioHub Facility, intended to facilitate the sharing of pathogens globally.
List view / Grid view
The WHO and Swiss Confederation are set to launch a BioHub Facility, intended to facilitate the sharing of pathogens globally.
Our comprehensive portfolio suite is designed to optimize your productivity to get safe and efficacious vaccines and therapeutics to market faster.
Dmytro Spilka explains why UK biotech companies are receiving increasing levels of investment and why this trend is likely to continue.
The UK Government will invest £29.3 million to test the effectiveness of COVID-19 vaccines against variants in 3,000 blood samples a week.
A summit will be held between the UK and CEPI to raise funds for vaccine research and development in a bid to avert future pandemics.
UK Health Secretary Matt Hancock has announced £37 million of funding for genomics and data projects to support the life sciences sector.
The UK has launched the Pandemic Preparedness Partnership which will advise the G7 Presidency how to reduce vaccine development time from 300 to 100 days.
Working with RNA requires rigorous nuclease contamination controls in place. Stock up on Nuclease-Free tubes tips and buffers #Back2Lab
RiboMinus Bacteria 2.0 Transcriptome Isolation Kits perform efficient transcriptome enrichment from total bacterial RNA. Improve your RNA extraction from bacteria today.
With the right solution organisations can simplify their lab-based working, while ensuring the highest level of compliance with regulatory requirements.
Between January and October 2020, scientists globally have published more than 87,000 papers about the coronavirus.
The UK Government will give £18.5 million in funding to four studies researching the causes and potential treatments of long COVID.
A report has been backed by eight industry leaders who say that updating R&D tax credit systems in the UK would release £4 billon of growth every year.
In this ebook, we’ll see how digitally enabling your organisation can increase capacity and improve vaccine production.
The UK Government has said genomics expertise will be offered to countries around the world to identify new variants of SARS-CoV-2.